Naomi Hammond's Publications

About Naomi Hammond's Publications

Program Head
  • Associate Professor, Faculty of Medicine, UNSW Sydney
  • RN,
  • BN,
  • MN (Crit. Care),
  • MPH (with Merit),
  • PhD

  • Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    Date published:

  • Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    Date published:

  • Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases Date published:

  • Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method

    The Lancet Infectious Diseases Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

    Intensive Care Medicine Date published:

  • Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

    JAMA: The Journal of the American Medical Association Date published:

  • The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study

    Critical Care Date published:

  • Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19

    JAMA Date published:

  • Long-Term Functional Outcomes After Sepsis for Adult and Pediatric Critical Care Patients-Protocol for a Systematic Review

    Frontiers in Pediatrics Date published:

  • Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis

    Critical Care and Resuscitation Date published:

  • Critical care health professionals’ self-reported needs for wellbeing during the COVID-19 pandemic: a thematic analysis of survey responses

    Australian Critical Care Date published:

  • Balanced crystalloids compared to normal saline for fluid therapy in critically ill adult patients: Systematic review and meta-analysis protocol

    medRxiv Date published:

  • Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

    Unknown Date published:

  • Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

    Intensive Care Medicine Date published:

  • Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand

    Australian Critical Care Date published:

  • Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial

    Acta Anaesthesiologica Scandinavica Date published: